Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats

Fenofibrate is a selective peroxisome proliferator-activated receptor α (PPARα) activator and is prescribed to treat hyperlipidemia. The mechanism through which PPARα agonists reduce food intake, body weight, and adiposity remains unclear. One explanation for the reduction of food intake is that fen...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Mi-Kyoung, Han, Ying, Kim, Mi Sun, Seo, Eunhui, Kang, Soojeong, Park, So-Young, Koh, Hyeongjong, Kim, Duk Kyu, Lee, Hye-Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394920/
https://www.ncbi.nlm.nih.gov/pubmed/22802699
http://dx.doi.org/10.4196/kjpp.2012.16.3.181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394920/
https://www.ncbi.nlm.nih.gov/pubmed/22802699
http://dx.doi.org/10.4196/kjpp.2012.16.3.181

Ejemplares similares